Immune Defences: A View from the Side of the Essential Oils.
Vivian TullioJanira RoanaLorenza CavalloNarcisa MandrasPublished in: Molecules (Basel, Switzerland) (2023)
The use of essential oils is increasingly being investigated among new therapeutic approaches based on medicinal plants and their extracts. With the wide use of synthetic and semi-synthetic antimicrobial drugs, the spread of drug-resistant clinical isolates has increased, and research is directed towards natural products, such as essential oils, as useful antimicrobial resources. In the context of a prospective infection, we compared the impact of essential oils and common antimicrobial agents on the microbicidal activity of human phagocytes. Here, we present the results of our decades-long investigation into the effectiveness of thyme red oil (26.52% thymol chemotype), tea tree oil (TTO), and Mentha of Pancalieri [( Mentha x piperita (Huds) var. officinalis (Sole), form rubescens (Camus) ( Lamiaceae )] essential oils on human polymorphonuclear leukocytes (PMNs) capacity to kill clinical strains of Candida albicans and C. krusei when compared to three antifungal drugs used to treat candidiasis (fluconazole, anidulafungin, and caspofungin) These essential oils demonstrate antifungal drug-like and/or superior efficacy in enhancing intracellular killing by PMNs, even at subinhibitory concentrations. Our results are compared with data in the literature on essential oils and immune system interactions. This comparison would aid in identifying therapeutic solutions to the increasingly prevalent antibiotic resistance as well as filling in any remaining knowledge gaps on the bioactivity of essential oils.
Keyphrases
- candida albicans
- drug resistant
- biofilm formation
- endothelial cells
- staphylococcus aureus
- multidrug resistant
- systematic review
- induced pluripotent stem cells
- healthcare
- randomized controlled trial
- acinetobacter baumannii
- escherichia coli
- pluripotent stem cells
- fatty acid
- emergency department
- machine learning
- cystic fibrosis
- reactive oxygen species
- electronic health record
- single molecule